• Cite/Export
  Cite/Export

  Copy a citation

  APA (6th ed.)

  

  Chicago (Author-Date, 15th ed.)

  

  Harvard (18th ed.)

  

  MLA (7th ed.)

  

  Turabian (6th ed.)

  

  Export a citation

  Export to RefWorks   Export to EndNote / Reference Manager   Export to EasyBib
  Export to EndNote / Reference Manager(non-Latin)   Cancel

  Note: Citations are based on reference standards. However, formatting rules can vary widely between applications and fields of interest or study. The specific requirements or preferences of your reviewing publisher, classroom teacher, institution or organization should be applied.
• Print
• E-mail
  E-mail

  All fields are required.

  The E-mail Address(es) field is required. Please enter recipient e-mail address(es).

  The E-mail Address(es) you entered is(are) not in a valid format. Please re-enter recipient e-mail address(es).

  You may send this item to up to five recipients.

  Enter recipient e-mail address(es): Separate up to five addresses with commas (,)

  The name field is required. Please enter your name.

  Enter your name: The subject field is required. Please enter the subject. Subject:

  The E-mail message field is required. Please enter the message.

  E-mail Message: I thought you might be interested in this item at http://pcc.worldcat.org/oclc/869139301 Title: The $800 million pill : the truth behind the cost of new drugs Author: Merrill Goozner Publisher: Berkeley : University of California Press, ©2004. ISBN/ISSN: 0520239458 9780520239456 OCLC:869139301

  
  

  Please verify that you are not a robot.

  Cancel
• Share
• Permalink
  Permalink

  Copy this URL to link to this page:

More like this

Subjects

• Prescription pricing.
• Drugs -- Prices.
• Pharmaceutical industry.
• View all subjects

Similar Items

The $800 million pill : the truth behind the cost of new drugs

Author:	Merrill Goozner
Publisher:	Berkeley : University of California Press, ©2004.
Edition/Format:	Print book : EnglishView all editions and formats
Summary:	This is an useful text for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries.  Read more...